Xiangxue Pharmaceutical - Asset Resilience Ratio

Latest as of March 2024: 0.05%

Xiangxue Pharmaceutical (300147) has an Asset Resilience Ratio of 0.05% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See working capital position of Xiangxue Pharmaceutical to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥4.00 Million

≈ $585.33K USD Cash + Short-term Investments

Total Assets

CN¥8.24 Billion

≈ $1.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2024)

This chart shows how Xiangxue Pharmaceutical's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is Xiangxue Pharmaceutical's balance sheet.

Liquid Assets Composition Over Time

This chart breaks down Xiangxue Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300147 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥4.00 Million	0.05%
Total Liquid Assets	CN¥4.00 Million	0.05%

Asset Resilience Insights

Limited Liquidity: Xiangxue Pharmaceutical maintains only 0.05% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Xiangxue Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Xiangxue Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	2.50%
Dianthus Therapeutics Inc. NASDAQ:DNTH	Biotechnology	63.98%
Tango Therapeutics Inc NASDAQ:TNGX	Biotechnology	62.24%
Damora Therapeutics, Inc. NASDAQ:DMRA	Biotechnology	0.00%
Wecome Pharmaceutical Co Ltd SHE:300878	Biotechnology	0.67%
Tectonic Therapeutic, Inc. NASDAQ:TECX	Biotechnology	86.66%
Relmada Therapeutics Inc NASDAQ:RLMD	Biotechnology	95.25%
MediWound Ltd F:M8W	Biotechnology	56.04%

Annual Asset Resilience Ratio for Xiangxue Pharmaceutical (2010–2024)

The table below shows the annual Asset Resilience Ratio data for Xiangxue Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.17%	CN¥13.00 Million ≈ $1.90 Million	CN¥7.50 Billion ≈ $1.10 Billion	+0.67pp
2023-12-31	-0.49%	CN¥-40.87 Million ≈ $-5.98 Million	CN¥8.28 Billion ≈ $1.21 Billion	-0.49pp
2022-12-31	0.00%	CN¥125.98K ≈ $18.43K	CN¥9.35 Billion ≈ $1.37 Billion	-0.58pp
2021-12-31	0.58%	CN¥65.63 Million ≈ $9.60 Million	CN¥11.38 Billion ≈ $1.67 Billion	+0.38pp
2020-12-31	0.20%	CN¥19.34 Million ≈ $2.83 Million	CN¥9.78 Billion ≈ $1.43 Billion	-0.14pp
2019-12-31	0.34%	CN¥28.54 Million ≈ $4.18 Million	CN¥8.46 Billion ≈ $1.24 Billion	+0.07pp
2018-12-31	0.27%	CN¥23.34 Million ≈ $3.41 Million	CN¥8.63 Billion ≈ $1.26 Billion	+0.44pp
2017-12-31	-0.17%	CN¥-16.17 Million ≈ $-2.37 Million	CN¥9.44 Billion ≈ $1.38 Billion	-0.50pp
2016-12-31	0.33%	CN¥26.36 Million ≈ $3.86 Million	CN¥7.99 Billion ≈ $1.17 Billion	-0.13pp
2015-12-31	0.46%	CN¥21.27 Million ≈ $3.11 Million	CN¥4.65 Billion ≈ $680.73 Million	+0.64pp
2014-12-31	-0.18%	CN¥-6.46 Million ≈ $-944.87K	CN¥3.59 Billion ≈ $525.08 Million	-0.19pp
2010-12-31	0.01%	CN¥203.67K ≈ $29.80K	CN¥1.85 Billion ≈ $270.22 Million	--

pp = percentage points

About Xiangxue Pharmaceutical

SHE:300147 China Biotechnology

Market Cap

$631.88 Million

CN¥4.32 Billion CNY

Market Cap Rank

#11149 Global

#3113 in China

Share Price

CN¥6.53

Change (1 day)

+1.08%

52-Week Range

CN¥6.25 - CN¥11.18

All Time High

CN¥25.81